Australian Regenerative Medicine Institute

What Australian Regenerative Medicine Institute does

The Australian Regenerative Medicine Institute (ARMI) is a medical research centre established in April 2009 with a reported $153 million capital base, located in Clayton, Australia. Per the firmographic record, it is classified as a for-profit entity, though its functional posture is that of a dedicated research institute rather than a commercial operator. ARMI operates in the specialized field of regenerative medicine, and its organizational design — including a dedicated Director, External Strategy and Planning role currently held by Silvio Tiziani — indicates institutional emphasis on partnerships and external engagement with funding bodies, academic collaborators, and the broader biomedical ecosystem.

The institute's core activity is regenerative medicine research; however, the available source data does not enumerate specific research programs, technology platforms, proprietary models, intellectual property holdings, or commercial product pipelines. The primary website (armi.org.au) returned only a loading/verification page during data collection, and no product, technology, or AI capability details were extracted. ARMI's co-location in the Clayton biomedical precinct situates it within a recognized Australian research cluster, providing access to affiliated universities, hospitals, and translational infrastructure.

ARMI's revenue model is not commercial in the conventional sense. The pricing notes explicitly indicate that the institute likely operates through research grants, institutional funding, and academic collaborations rather than product or service pricing. No disclosed revenue, funding rounds, customer base, headcount, or pricing model details are available. The $153 million figure represents cumulative institutional investment since the 2009 opening rather than annual revenue, making direct revenue benchmarking not feasible from the available data.

Name

Australian Regenerative Medicine Institute

Website

https://armi.org.au

Company type

Private

Founded year

2009

Short description

The Australian Regenerative Medicine Institute is a $153 million medical research centre in Clayton, Australia, established in April 2009. It conducts regenerative medicine research, operating through research grants, institutional funding, and academic collaborations rather than commercial revenue.

Ownership category

akta.pro rank

Product category

Regenerative Medicine Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAAAGAA

Stem Cell–Based Regenerative Therapies

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

• Regenerative medicine research
• Medical research institute
• Stem cell research
• Biomedical research
• Tissue engineering research

Headquarters

HQ city

Clayton

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Core offering

The Australian Regenerative Medicine Institute is a $153 million medical research centre based in Clayton, Australia, that officially opened in April 2009. It conducts research in regenerative medicine, a field focused on developing methods to regrow, repair, or replace damaged or diseased cells, organs, and tissues. Specific product or service offerings could not be extracted from the source data, which consisted of a loading/verification page.

Differentiator

Problem solved

Functional benefit

Products and services

• Regenerative Medicine Research Services Medical research services in regenerative medicine conducted at the ARMI facility in Clayton, Australia.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Emerging players

• Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW): International consortium focused on stem cell-based regenerative therapies. Comparable mission in stem cell-driven regenerative medicine, though operating as an international consortium rather than a single-site institute like ARMI.

Direct peers

• Cincinnati Children's Center for Stem Cell and Organoid Medicine: Hospital-affiliated centre focused on stem cell biology and regenerative applications. Comparable to ARMI as a translational stem cell research platform within a major academic medical ecosystem.
• McGowan Institute for Regenerative Medicine: University of Pittsburgh-based regenerative medicine institute conducting translational research in tissue engineering and cell-based therapies. Highly comparable in mission, scale, and academic affiliation to ARMI.
• Wake Forest Institute for Regenerative Medicine: One of the world's largest regenerative medicine research institutes, focused on engineering tissues and organs. Directly comparable to ARMI as a dedicated, large-scale academic regenerative medicine research centre pursuing translational therapies.
• Centre for Regenerative Medicine (University of Edinburgh): Academic regenerative medicine research centre conducting stem cell and tissue engineering research. Comparable to ARMI in mission, public funding model, and translational orientation.

Regional players

• Murdoch Children's Research Institute: Leading Australian paediatric research institute with regenerative medicine programmes. Comparable in scale, funding structure, and translational research focus within the Australian biomedical landscape.
• Garvan Institute of Medical Research: Major Australian medical research institute with strength in cell biology and genomics. Regionally comparable peer sharing funding model, scale, and translational ambitions with ARMI.

Broad incumbents

• Monash University (Faculty of Medicine, Nursing and Health Sciences): Host institution located in Clayton, of which ARMI is part of the broader biomedical research portfolio. Comparable as the parent academic ecosystem providing governance, talent, and infrastructure to ARMI.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/ARMI_Labs
• Facebookfacebook.com/AustralianRegenerativeMedicineInstitute
• LinkedInlinkedin.com/company/australian-regenerative-medicine-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australian Regenerative Medicine Institute